- ►pipex.com [PDF] RR Holman, KI Thorne, AJ Farmer, MJ Davies, … - New England Journal of Medicine, 2007 - content.nejm.org From the Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and
Metabolism (RRH, KIT, AJF, JFK, SP, JCL) and the Department of Primary Health
Care (AJF), University of Oxford, Oxford; and the Department of Cardiovas- ... Cited by 134 - Related articles - BL Direct - All 12 versions
A Rolla - The American Journal of Medicine, 2008 - Elsevier Human insulin preparations administered to patients with diabetes mellitus fail
to reproduce the normal physiologic pattern of insulin secretion. Modifications
have been made in the amino acid sequence of the insulin molecule with the ... Cited by 15 - Related articles - All 17 versions
- ►canadianmedicaljournal.ca SR Singh, BSP MSc, F Ahmad, A Lal, C Yu, Z … - Canadian Medical Association Journal, 2009 - Can Med Assoc Methods: We updated 2 earlier systematic reviews of the efficacy and safety of
rapid-and long-acting insulin analogues. We searched electronic databases,
conference proceedings and "grey literature" up to April 2007 to identify ... Cited by 13 - Related articles - All 12 versions
L Monnier, M Benichou, S Charra-Ebrard, C … - Diabetes and Metabolism, 2005 - Elsevier Therapeutic strategies in type 2 diabetic patients should not only integrate
both the targets and indications of the different therapies but should be also a
compromise between the patient's and physician's goals and willingnesses. ... Cited by 10 - Related articles - All 4 versions
D Owens, J Vora - Expert Opin. Drug Metab. Toxicol., 2006 - informahealthcare.com Insulin aspart, an analogue of human insulin, which is approved for use in
people with diabetes, is more rapidly absorbed and achieves higher plasma
concentrations than human soluble insulin following subcutaneous injection. ... Cited by 6 - Related articles - BL Direct - All 6 versions
DM Karl - Current Diabetes Reports, 2004 - Springer Introduction Relative insulin deficiency, a defect that worsens progres- sively
over time, is now recognized to be an essential feature of type 2 diabetes
mellitus [1]. Because of this natu- ral history, most patients with type 2 ... Cited by 4 - Related articles - BL Direct - All 2 versions
A Haycox - Clinical drug investigation, 2004 - ingentaconnect.com This paper provides a review and evaluation of the published evidence relating
Abstract to the efficacy, safety and ease of administration of the rapid-acting
insulin analogue insulin aspart in comparison with human insulin (HI) in ... Cited by 4 - Related articles - All 4 versions
E Mannucci, M Monami, N Marchionni - Diabetes, Obesity and Metabolism, 2009 - interscience.wiley.com Conflicts of interest: All authors have seen and approved the final version. EM
has the following conflicts of interest: (i) speaking fees from Eli Lilly, Novo
Nordisk and Sanofi Aventis; (ii) consultancy fees from Sanofi Aventis; ... Cited by 3 - Related articles - All 3 versions
T Heise, U Eckers, K Kanc, JN Nielsen, L … - Diabetes Technology & Therapeutics, 2008 - liebertonline.com Background: Type 2 diabetes patients on premixed insulin are commonly prescribed
biphasic insulin with low prandial insulin content, such as biphasic insulin
aspart (BIAsp) 30, comprising 30% insulin aspart (IAsp). The new ... Cited by 3 - Related articles - All 3 versions
